Opaleye Management Inc.'s Form 4 filing
Protara Therapeutics, Inc. (TARA) · filed Apr 8, 2022
- Accession no.
- 0001493152-22-009511
- Filed
- Apr 8, 2022
- Trade date
- Apr 7-8, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market purchases total $48.5K. It was filed 1 day after the trade.
This filing was later replaced by the amendment 0001493152-22-010003 (Apr 15, 2022). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Opaleye Management Inc.CIK 0001595855 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 7, 2022 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +1,345 | $4.74 | +$6,375.3 | 2,551,345 | Indirect | |
| Apr 7, 2022 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +1,000 | $4.74 | +$4,740 | 125,031 | Indirect | |
| Apr 8, 2022 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +5,322 | $4.80 | +$25,545.6 | 2,556,667 | Indirect | |
| Apr 8, 2022 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +2,469 | $4.80 | +$11,851.2 | 127.5 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.